# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hereditary angioedema

HAE
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 16 results.
Hereditary Angioedema Kininogen Assay
Status: Recruiting
Last Changed: Sep 16, 2019
First Received: Sep 16, 2019
Disease(s): Hereditary Angioedema
Intervention(s): Withdraw of blood
Locations: Centogene AG, Rostock, Germany
A Study to Assess the Clinical Efficacy of IONIS-PKK-LRx in Participants With Hereditary Angioedema
Status: Not yet recruiting
Last Changed: Aug 08, 2019
First Received: Jul 24, 2019
Disease(s): Hereditary Angioedema
Intervention(s): IONIS PKK-LRx, Placebo
A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)
Status: Recruiting
Last Changed: Aug 22, 2019
First Received: Oct 19, 2018
Disease(s): Hereditary Angioedema
Intervention(s): Factor XIIa antagonist monoclonal antibody, Placebo
Locations: Clinical Research Center of Alabama, Birmingham, Alabama, United States
Donald S. Levy, Orange, California, United States
Allergy & Asthma Clinical Research, Walnut Creek, California, United States
Immunoe Health Centers, Centennial, Colorado, United States
Institute for Asthma and Allergy, Chevy Chase, Maryland, United States
... and 16 other locations.
Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II
Status: Recruiting
Last Changed: Feb 05, 2019
First Received: Feb 04, 2019
Disease(s): Hereditary Angioedema Type I and II
Intervention(s): functional and antigenic C1 inhibitor
Locations: ASST FBF Sacco, Milan, Italy
Study to Evaluate the Real-world Effectiveness of Lanadelumab in Participants With Hereditary Angioedema (HAE)
Status: Recruiting
Last Changed: Jul 02, 2019
First Received: Feb 19, 2019
Disease(s): Hereditary Angioedema (HAE)
Locations: Clinical Research Center of Alabama, Birmingham, Alabama, United States
Medical Research of Arizona, Scottsdale, Arizona, United States
AIRE Medical of Los Angeles, Santa Monica, California, United States
Asthma and Allergy Associates, PC, Colorado Springs, Colorado, United States
Yale University School of Medicine, New Haven, Connecticut, United States
... and 22 other locations.
Patient Registry to Evaluate the Real-world Safety of Ruconest®
Status: Recruiting
Last Changed: Oct 05, 2018
First Received: Oct 05, 2018
Disease(s): Hereditary Angioedema
Intervention(s): rhC1INH
Locations: The US Hereditary Angioedema Association, Fairfax, Virginia, United States
A Long Term Safety Study of BCX7353 in Hereditary Angioedema
Status: Recruiting
Last Changed: Sep 13, 2019
First Received: Mar 21, 2018
Disease(s): Hereditary Angioedema, HAE, Prophylaxis
Intervention(s): BCX7353
Locations: Study Center, Birmingham, Alabama, United States
Study Center, Little Rock, Arkansas, United States
Study Center, Tampa, Florida, United States
Study Center, Chevy Chase, Maryland, United States
Study Center, Saint Louis, Missouri, United States
... and 50 other locations.
C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks
Status: Recruiting
Last Changed: Jun 19, 2019
First Received: Jul 20, 2011
Disease(s): Hereditary Angioedema
Intervention(s): rhC1INH or pdC1INH
Locations: UMHAT Alexandrovska EAD, Sofia, Bulgaria
KBC Split, Split, Croatia
CHC Sestre milosrdnice, Zagreb, Croatia
General Hospital Sibenik, Šibenik, Croatia
Faculty Hospital by St. Anna Brno, Brno, Czechia
... and 13 other locations.
A Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Pediatric Participants of 2 Years to Less Than (<) 12 Years of Age
Status: Not yet recruiting
Last Changed: Aug 27, 2019
First Received: Aug 27, 2019
Disease(s): Hereditary Angioedema (HAE)
Intervention(s): Lanadelumab
Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)
Status: Recruiting
Last Changed: Jun 04, 2019
First Received: Dec 18, 2009
Disease(s): Hereditary Angioedema (HAE)
Locations: Campbelltown Hospital, Campbelltown, New South Wales, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Medizinische Universität Graz, Graz, Steiermark, Austria
Faculdade de Medicina Do ABC, Santo André, Sao Paulo, Brazil
Fakultni nemocnice u sv. Anny v Brne, Brno, Czechia
... and 66 other locations.